Zurich Cantonal Bank
ABOS icon

Zurich Cantonal Bank’s Acumen Pharmaceuticals ABOS Stock Holding History

Zurich Cantonal Bank’s Portfolio ABOS Stock Details ABOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-413
Closed -$1.59K – 2707
2023
Q4 		$1.59K Sell
413
-2,980
-88% -$8.85K ﹤0.01% 2692
2023
Q3 		$14.1K Buy
+3,393
New +$21K ﹤0.01% 2724

Other funds holding ABOS

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KIA
Knollwood Investment Advisory Hunt Valley, Maryland $992M AUM 28.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Zurich Cantonal Bank's ABOS Position: Q1 2024 in Review

Zurich Cantonal Bank sold out of Acumen Pharmaceuticals (ABOS) in Q1 2024, closing a stake of 413 shares — an estimated $1.59K sold.

Zurich Cantonal Bank first reported a position in ABOS in Q3 2023 and held it in 2 quarters. The position peaked at $14.1K in Q3 2023. 80 funds tracked by Wall St. Rank hold ABOS as of Q1 2024.

  • Zurich Cantonal Bank reported no remaining Acumen Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Zurich Cantonal Bank sold 413 Acumen Pharmaceuticals shares in Q1 2024, an estimated $1.59K.
  • Zurich Cantonal Bank first reported a position in Acumen Pharmaceuticals in Q3 2023 and held it in 2 quarters.
  • Zurich Cantonal Bank's Acumen Pharmaceuticals position peaked at $14.1K in Q3 2023.
  • 80 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q1 2024.

Based on Zurich Cantonal Bank's 13F filing for Q1 2024, filed 25 Apr 2024.